Artwork

Nội dung được cung cấp bởi Executive Platforms. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Executive Platforms hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Player FM - Ứng dụng Podcast
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !

Controlling Costs through Continuous Manufacturing of Biopharmaceuticals — A Conversation with Jon Gunther of Just – Evotec Biologics

21:53
 
Chia sẻ
 

Manage episode 424223851 series 3580470
Nội dung được cung cấp bởi Executive Platforms. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Executive Platforms hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

At the 2023 edition of the Biomanufacturing World Summit series we sat down with Jon Gunther of Just – Evotec Biologics to talk about why biopharmaceutical manufacturing is behind the curve when it comes to controlling its costs, and what lessons senior leaders can take from other industries as they work to rein in expenses. One important idea explored at length is the advantage pivoting from batch manufacturing to continuous manufacturing would offer the Life Sciences in terms of reducing operating costs, costs of goods, labor costs, and more. What does making that switch look like in real terms? What do companies need to do to prepare their people, processes, and systems for change, and who can they look to for guidance and assistance as they transform themselves? How can companies model their product workflow and output before committing themselves to the transition, and what kind of platform will allow for the smoothest possible move between production models? Give this episode a listen for answers to these questions and more!

--

Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform company that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com

  continue reading

231 tập

Artwork
iconChia sẻ
 
Manage episode 424223851 series 3580470
Nội dung được cung cấp bởi Executive Platforms. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Executive Platforms hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

At the 2023 edition of the Biomanufacturing World Summit series we sat down with Jon Gunther of Just – Evotec Biologics to talk about why biopharmaceutical manufacturing is behind the curve when it comes to controlling its costs, and what lessons senior leaders can take from other industries as they work to rein in expenses. One important idea explored at length is the advantage pivoting from batch manufacturing to continuous manufacturing would offer the Life Sciences in terms of reducing operating costs, costs of goods, labor costs, and more. What does making that switch look like in real terms? What do companies need to do to prepare their people, processes, and systems for change, and who can they look to for guidance and assistance as they transform themselves? How can companies model their product workflow and output before committing themselves to the transition, and what kind of platform will allow for the smoothest possible move between production models? Give this episode a listen for answers to these questions and more!

--

Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform company that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com

  continue reading

231 tập

Tất cả các tập

×
 
Loading …

Chào mừng bạn đến với Player FM!

Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.

 

Hướng dẫn sử dụng nhanh